Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-16

Clinical Trial Update: Special Drug Use Investigation for VALTREX (Valaciclovir) (Suppression Prophylaxis)

View source ↗

Summary

A completed clinical trial update on the use of valaciclovir (Valtrex) for suppression prophylaxis in genital herpes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VALTREX (valacyclovir hydrochloride)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Genital Herpes | Status: COMPLETED